headlines

TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan

iStock/aniszewski

TPI Enterprises has bought Vistin Pharma ASA’s opiates and tabletting division for A$25.4m ($201.m) in a deal designed to expand the firm beyond its narcotic raw materials business.

GSK House in Brentford, UK (source GSK)

GSK says UK manufacturing cuts not Brexit related

iStock/Bet_Noire

WHO prequalifies Mylan's India unit to supply TB drug API

iStock/ronstik

The serialisation stragglers: industry concern for complacency

iStock/AdrianHancu

EU to probe if drug firms' pre-submission meetings sway EMA approval decisions

iStock/OBray

Glenmark selects Cyndea to make gel capsule drugs

iStock/jarun011

US FDA reaffirms hold on oral Proellex trials prompting Repros rethink

Tubilux Pharma SPA in Pomezia (source Google maps)

US FDA warns opthalmic supplier Tubilux about Italian plant

iStock/shironosov

Pfizer hires Catalent to make smaller format Advil using Optigel tech

iStock/Rost-9D

US FDA to decide on Spark's vision loss gene therapy Luxturna in January

See More headlines